Serum β-carotene in relation to risk of prostate cancer: The Kuopio ischaemic heart disease risk factor study

Nutrition and Cancer

Volumn 64, Issue 3, 2012, Pages 361-367

  Karppi, Jouni ^a   Kurl, Sudhir ^a   Laukkanen, Jari A ^a,b   Kauhanen, Jussi ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b LAPLAND CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CAROTENE; CHOLESTEROL; LINOLENIC ACID; RETINOL; TOCOPHEROL;

ADULT; ALCOHOL CONSUMPTION; ANTHROPOMETRY; ARTICLE; BETA CAROTENE BLOOD LEVEL; BODY MASS; CANCER RISK; CHOLESTEROL BLOOD LEVEL; DISEASE ASSOCIATION; FOLLOW UP; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; PROSTATE CANCER; RISK FACTOR; VITAMIN BLOOD LEVEL;

ADULT; AGED; ALCOHOL DRINKING; ALPHA-LINOLENIC ACID; ALPHA-TOCOPHEROL; ANTIOXIDANTS; BETA CAROTENE; CHOLESTEROL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FINLAND; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; QUESTIONNAIRES; RISK FACTORS; SMOKING; VITAMIN A;

EID: 84859741434     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2012.658949     Document Type: Article

References (43)

1. Baade, P D, Youlden, D R, and, Krnjacki, L J. 2009. International epidemiology of prostate cancer: geographical distribution and secular trends. Mol Nutr Food Res, 53: 171-184.
2. Sonn, G A, Aronson, W, and, Litwin, M S. 2005. Impact of diet on prostate cancer: a review. Prostate Cancer Prostatic Dis, 8: 304-310. (Pubitemid 43078163)
3. Chan, J M, Gann, P H, and, Giovannucci, E L. 2005. Role of diet in prostate cancer development and progression. J Clin Oncol, 23: 8152-8160. (Pubitemid 46211548)
4. Allen, N E, Key, T J, Appleby, P N, Travis, R C, Roddam, A W. 2008. Animal foods, protein, calcium and prostate cancer risk: the European Prospective Investigation Into Cancer and Nutrition. Br J Cancer, 98: 1574-1581. (Pubitemid 351652328)
5. Giovannucci, E, Liu, Y, Platz, E A, Stampfer, M J, and, Willett, W C. 2007. Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int J Cancer, 121: 1571-1578. (Pubitemid 47328718)
6. Miyake, H, Hara, I, Kamidono, S, and, Eto, H. 2004. Oxidative DNA damage in patients with prostate cancer and its response to treatment. J Urol, 171: 1533-1536. (Pubitemid 38365412)
7. Bostwick, D G, Alexander, E E, Singh, R, Shan, A, Qian, J. 2000. Antioxidant enzyme expression and reactive oxygen species damage in prostatic intraepithelial neoplasia and cancer. Cancer, 89: 123-134. (Pubitemid 30451282)
8. Krinsky, N I, and, Johnson, E J. 2005. Carotenoid actions and their relation to health and disease. Mol Aspects Med, 26: 459-516. (Pubitemid 41741836)
9. Huang, H Y, Alberg, A J, Norkus, E P, Hoffman, S C, Comstock, G W. 2003. Prospective study of antioxidant micronutrients in the blood and the risk of developing prostate cancer. Am J Epidemiol, 157: 335-344. (Pubitemid 36193936)
10. Kristal, A R. 2004. Vitamin A, retinoids and carotenoids as chemopreventive agents for prostate cancer. J Urol, 171: S54-S58. discussion S58 (Pubitemid 38090424)
11. Blomhoff, R. 1994. Vitamin A in health and disease., New York: Marcel Dekker.
12. Wu, K, Erdman, J W Jr., Schwartz, S J, Platz, E A, Leitzmann, M. 2004. Plasma and dietary carotenoids, and the risk of prostate cancer: a nested case-control study. Cancer Epidemiol Biomarkers Prev, 13: 260-269. (Pubitemid 38222558)
13. Bosetti, C, Talamini, R, Montella, M, Negri, E, Conti, E. 2004. Retinol, carotenoids and the risk of prostate cancer: a case-control study from Italy. Int J Cancer, 112: 689-692. (Pubitemid 39425951)
14. Lu, Q Y, Hung, J C, Heber, D, Go, V L, Reuter, V E. 2001. Inverse associations between plasma lycopene and other carotenoids and prostate cancer. Cancer Epidemiol Biomarkers Prev, 10: 749-756. (Pubitemid 32695154)
15. Jian, L, Du, C J, Lee, A H, and, Binns, C W. 2005. Do dietary lycopene and other carotenoids protect against prostate cancer?. Int J Cancer, 113: 1010-1014. (Pubitemid 40096883)
16. Chang, S, Erdman, J W Jr., Clinton, S K, Vadiveloo, M, Strom, S S. 2005. Relationship between plasma carotenoids and prostate cancer. Nutr Cancer, 53: 127-134.
17. Schuurman, A G, Goldbohm, R A, Brants, H A, and, van den Brandt, P A. 2002. A prospective cohort study on intake of retinol, vitamins C and E, and carotenoids and prostate cancer risk (Netherlands). Cancer Causes Control, 13: 573-582. (Pubitemid 34833109)
18. Zhang, J, Dhakal, I, Stone, A, Ning, B, Greene, G. 2007. Plasma carotenoids and prostate cancer: a population-based case-control study in Arkansas. Nutr Cancer, 59: 46-53. (Pubitemid 47549780)
19. Vogt, T M, Mayne, S T, Graubard, B I, Swanson, C A, Sowell, A L. 2002. Serum lycopene, other serum carotenoids, and risk of prostate cancer in U.S. blacks and whites. Am J Epidemiol, 155: 1023-1032. (Pubitemid 34587486)
20. Key, T J, Appleby, P N, Allen, N E, Travis, R C, Roddam, A W. 2007. Plasma carotenoids, retinol, and tocopherols and the risk of prostate cancer in the European prospective investigation into cancer and nutrition study. Am J Clin Nutr, 86: 672-681. (Pubitemid 47435834)
21. Peters, U, Leitzmann, M F, Chatterjee, N, Wang, Y, Albanes, D. 2007. Serum lycopene, other carotenoids, and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev, 16: 962-968. (Pubitemid 46910098)
22. Rissanen, T H, Voutilainen, S, Nyyssnen, K, Lakka, T A, Sivenius, J. 2001. Low serum lycopene concentration is associated with an excess incidence of acute coronary events and stroke: the kuopio ischaemic heart disease risk factor study. Br J Nutr, 85: 749-754. (Pubitemid 32586506)
23. Thurnham, D I, Smith, E, and, Flora, P S. 1988. Concurrent liquid-chromatographic assay of retinol, alpha-tocopherol, beta-carotene, alpha-carotene, lycopene, and beta-cryptoxanthin in plasma, with tocopherol acetate as internal standard. Clin Chem, 34: 377-381. (Pubitemid 18064994)
24. Salonen, J T, Nyyssnen, K, Korpela, H, Tuomilehto, J, Seppnen, R. 1992. High stored iron levels are associated with excess risk of myocardial infarction in Eastern Finnish men. Circulation, 86: 803-811.
25. Teppo, L, Pukkala, E, and, Lehtonen, M. 1994. Data quality and quality control of a population-based cancer registry: experience in Finland. Acta Oncol, 33: 365-369. (Pubitemid 24207996)
26. Finnish Cancer Registry. 2007. Institute for Statistical and Epidemiological Cancer Research: Cancer in Finland 2004 and 2005. Cancer Statistics of the National Research and Development Centre for Welfare and Health, Helsinki: Cancer Society of Finland Publication no. 72.
27. Mursu, J, Nurmi, T, Tuomainen, T P, Salonen, J T, Pukkala, E. 2008. Intake of flavonoids and risk of cancer in Finnish men: the Kuopio Ischemic Heart Disease Risk Factor Study. Int J Cancer, 123: 660-663. (Pubitemid 351898425)
28. Brouwer, I A, Katan, M B, and, Zock, P L. 2004. Dietary alpha-linolenic acid is associated with reduced risk of fatal coronary heart disease, but increased prostate cancer risk: a meta-analysis. J Nutr, 134: 919-922. (Pubitemid 38456264)
29. Karppi, J, Nurmi, T, Olmedilla-Alonso, B, Granado-Lorencio, F, and, Nyyssnen, K. 2008. Simultaneous measurement of retinol, alpha-tocopherol and six carotenoids in human plasma by using an isocratic reversed-phase HPLC method. J Chromatogr B Analyt Technol Biomed Life Sci, 867: 226-232.
30. Virtamo, J, Pietinen, P, Huttunen, J K, Korhonen, P, Malila, N. 2003. Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. JAMA, 290: 476-485. (Pubitemid 37430501)
31. Hennekens, C H, Buring, J E, Manson, J E, Stampfer, M, Rosner, B. 1996. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med, 334: 1145-1149. (Pubitemid 26137972)
32. Neuhouser, M L, Barnett, M J, Kristal, A R, Ambrosone, C B, King, I B. 2009. Dietary supplement use and prostate cancer risk in the carotene and retinol efficacy trial. Cancer Epidemiol Biomarkers Prev, 18: 2202-2206.
33. Heart Protection Study Collaborative Group. 2002. MRC/BHF heart protection study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet, 360: 23-33.
34. Heinonen, O P, Albanes, D, Virtamo, J, Taylor, P R, Huttunen, J K. 1998. Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst, 90: 440-446. (Pubitemid 28160635)
35. Paolini, M, Abdel-Rahman, S Z, Sapone, A, Pedulli, G F, Perocco, P. 2003. Beta-carotene: a cancer chemopreventive agent or a co-carcinogen?. Mutat Res, 543: 195-200. (Pubitemid 36645079)
36. Goralczyk, R. 2009. Beta-carotene and lung cancer in smokers: review of hypotheses and status of research. Nutr Cancer, 61: 767-774.
37. Albanes, D, Virtamo, J, Taylor, P R, Rautalahti, M, Pietinen, P. 1997. Effects of supplemental beta-carotene, cigarette smoking, and alcohol consumption on serum carotenoids in the alpha-tocopherol, beta-carotene cancer prevention study. Am J Clin Nutr, 66: 366-372. (Pubitemid 27360336)
38. Lieber, C S, Baraona, E, Leo, M A, and, Garro, A. 1987. International Commission for Protection Against Environmental Mutagens and Carcinogens: ICPEMC Working Paper no. 15/2. Metabolism and metabolic effects of ethanol, including interaction with drugs, carcinogens and nutrition. Mutat Res, 186: 201-233.
39. Leo, M A, Kim, C, Lowe, N, and, Lieber, C S. 1992. Interaction of ethanol with beta-carotene: delayed blood clearance and enhanced hepatotoxicity. Hepatology, 15: 883-891.
40. Simon, J A, Chen, Y H, and, Bent, S. 2009. The relation of alpha-linolenic acid to the risk of prostate cancer: a systematic review and meta-analysis. Am J Clin Nutr, 89: 1558S-1564S.
41. De Stefani, E, Deneo-Pellegrini, H, Boffetta, P, Ronco, A, and, Mendilaharsu, M. 2000. Alpha-linolenic acid and risk of prostate cancer: a case-control study in Uruguay. Cancer Epidemiol Biomarkers Prev, 9: 335-338. (Pubitemid 30165448)
42. Chavarro, J E, Stampfer, M J, Li, H, Campos, H, Kurth, T. 2007. A prospective study of polyunsaturated fatty acid levels in blood and prostate cancer risk. Cancer Epidemiol Biomarkers Prev, 16: 1364-1370. (Pubitemid 47076865)
43. Carayol, M, Grosclaude, P, and, Delpierre, C. 2010. Prospective studies of dietary alpha-linolenic acid intake and prostate cancer risk: a meta-analysis. Cancer Causes Control, 21: 347-355.